COBAS 8000 E 602 MODULE E602

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,health professional,u report with the FDA on 2017-06-09 for COBAS 8000 E 602 MODULE E602 manufactured by Roche Diagnostics.

Event Text Entries

[77625801] Unique identifier (udi)#: (b)(4). This event occurred in (b)(6).
Patient Sequence No: 1, Text Type: N, H10


[77625802] The customer received questionable high elecsys afp assay results for multiple patient samples and suspected carryover from one sample tested prior to these samples that had a result of >60500 ng/ml. For one patient, the initial result was "80". The doctor doubted the result as it was not consistent with the previous results and clinical symptoms for the patient. As the sample had been discarded, a new sample was drawn from the patient on (b)(6) 2017. The result from the new sample was "1". Specific data for this sample was not provided. Data was provided for six patient samples questioned by the customer based on the previous result for the patient. These samples were discarded and could not be repeated. Data was also provided for one patient sample where the original sample and an additional sample from the day of the event were repeated. Refer to the attachment to the medwatch for all patient data. There was no allegation of an adverse event. The reagent lot number was 120174. The expiration date was requested but was not provided. The investigation reviewed all afp results provided from the day of the event and determined carryover from the high sample was not likely as the samples immediately following this sample did not have elevated results or data flags indicating carryover. Review of the provided calibration and qc data found all were acceptable and in range. Based on the provided data, a general device issue was excluded.
Patient Sequence No: 1, Text Type: D, B5


[117967345] A specific root cause could not be determined. Possible causes include an issue with the preanalytic handing of the samples. It was recommended to retest the patients with a new sample.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2017-01197
MDR Report Key6630795
Report SourceFOREIGN,HEALTH PROFESSIONAL,U
Date Received2017-06-09
Date of Report2017-07-06
Date of Event2017-03-21
Date Mfgr Received2017-05-26
Date Added to Maude2017-06-09
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1HITACHI HIGH TECH CORP.
Manufacturer Street882 ICHIGE HITACHINAKA NA
Manufacturer CityIBARAKI 312-8504
Manufacturer CountryJA
Manufacturer Postal Code312-8504
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Sequence Number: 0

Brand NameCOBAS 8000 E 602 MODULE
Generic NameIMMUNOCHEMISTRY ANALYZER
Product CodeCDZ
Date Received2017-06-09
Model NumberE602
Catalog NumberASKU
Lot NumberNA
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrR
Device Sequence No0
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457

Device Sequence Number: 1

Brand NameCOBAS 8000 E 602 MODULE
Generic NameIMMUNOCHEMISTRY ANALYZER
Product CodeJJE
Date Received2017-06-09
Model NumberE602
Catalog NumberASKU
Lot NumberNA
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2017-06-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.